Recordati Rare Diseases
Fabian Schmidt currently serves as the Global Head of Market Access, HEOR and Policy at Recordati Rare Diseases, overseeing pricing and market access for rare diseases and oncology products, with geographic responsibility excluding North America. Prior to this role, Fabian was an Executive Director at Ernst & Young S.L., contributing to life sciences strategy and pricing at the EMEIA Advisory Center. A significant portion of Fabian's career was spent at Simon-Kucher & Partners S.L., where responsibilities included managing a team of 25 staff and leading the Spanish Life Sciences Division while handling business development and project management. Fabian began professional experience as an intern at Volkswagen de Mexico, focusing on after sales and logistics. Educational background includes a Diplom-Kaufmann in Business Administration from the University of Bayreuth and University of Deusto, complemented by studies at Orange Coast College.
This person is not in any teams
This person is not in any offices
Recordati Rare Diseases
3 followers
Recordati Rare Diseases is a pharmaceutical company that provides treatment for patients with rare diseases. Created in 1990, Recordati Rare Diseases is one of the most active companies in the field of rare diseases.